John W. Beck, Chief Financial Officer at METABASIS THERAPEUTICS INC (MBRX), sold 3,300 shares at $8.13 ($27K) on 2007-04-25, disclosed to the SEC on 2007-04-25.
Scheduled sale ($27k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RDEA | SELL | 2009-08-17 | $50K | — | Filing → |
| RDEA | SELL | 2009-05-21 | $75K | — | Filing → |
| MBRX | SELL | 2007-06-21 | $27K | — | Filing → |